vs
National CineMedia, Inc.（NCMI）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是National CineMedia, Inc.的1.2倍（$75.5M vs $63.4M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 1.6%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-2.0M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -16.4%）
国家影院传媒是一家美国影院广告企业，依托由AMC、喜满客、 regal等头部连锁影院及区域影院院线组成的影院数字化网络，面向美国消费者，在影院场地、线上渠道以及移动端开展影院广告业务，是美国影院广告领域的核心运营商。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
NCMI vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.2倍
$63.4M
营收增速更快
PBYI
高出26.1%
1.6%
自由现金流更多
PBYI
多$16.4M
$-2.0M
两年增速更快
PBYI
近两年复合增速
-16.4%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $63.4M | $75.5M |
| 净利润 | $1.6M | — |
| 毛利率 | 95.0% | 69.3% |
| 营业利润率 | -2.8% | 22.7% |
| 净利率 | 2.5% | — |
| 营收同比 | 1.6% | 27.7% |
| 净利润同比 | 144.4% | — |
| 每股收益（稀释后） | $0.02 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NCMIPBYI
| Q4 25 | — | $75.5M | ||
| Q3 25 | $63.4M | $54.5M | ||
| Q2 25 | $51.8M | $52.4M | ||
| Q1 25 | $34.9M | $46.0M | ||
| Q4 24 | $86.3M | $59.1M | ||
| Q3 24 | $62.4M | $80.5M | ||
| Q2 24 | $54.7M | $47.1M | ||
| Q1 24 | $37.4M | $43.8M |
净利润NCMIPBYI
| Q4 25 | — | — | ||
| Q3 25 | $1.6M | $8.8M | ||
| Q2 25 | $-10.7M | $5.9M | ||
| Q1 25 | $-30.7M | $3.0M | ||
| Q4 24 | $24.7M | — | ||
| Q3 24 | $-3.6M | $20.3M | ||
| Q2 24 | $-8.7M | $-4.5M | ||
| Q1 24 | $-34.7M | $-4.8M |
毛利率NCMIPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | 95.0% | 77.7% | ||
| Q2 25 | 93.8% | 76.5% | ||
| Q1 25 | 91.1% | 77.1% | ||
| Q4 24 | 96.4% | 76.4% | ||
| Q3 24 | 94.7% | 63.9% | ||
| Q2 24 | 93.2% | 77.4% | ||
| Q1 24 | 90.4% | 75.5% |
营业利润率NCMIPBYI
| Q4 25 | — | 22.7% | ||
| Q3 25 | -2.8% | 17.6% | ||
| Q2 25 | -23.2% | 12.7% | ||
| Q1 25 | -68.5% | 8.7% | ||
| Q4 24 | 23.2% | 22.6% | ||
| Q3 24 | -12.0% | 27.4% | ||
| Q2 24 | -17.0% | -4.6% | ||
| Q1 24 | -60.7% | -5.3% |
净利率NCMIPBYI
| Q4 25 | — | — | ||
| Q3 25 | 2.5% | 16.2% | ||
| Q2 25 | -20.7% | 11.2% | ||
| Q1 25 | -88.0% | 6.5% | ||
| Q4 24 | 28.6% | — | ||
| Q3 24 | -5.8% | 25.2% | ||
| Q2 24 | -15.9% | -9.6% | ||
| Q1 24 | -92.8% | -11.0% |
每股收益（稀释后）NCMIPBYI
| Q4 25 | — | $0.26 | ||
| Q3 25 | $0.02 | $0.17 | ||
| Q2 25 | $-0.11 | $0.12 | ||
| Q1 25 | $-0.32 | $0.06 | ||
| Q4 24 | $0.26 | $0.40 | ||
| Q3 24 | $-0.04 | $0.41 | ||
| Q2 24 | $-0.09 | $-0.09 | ||
| Q1 24 | $-0.36 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $29.9M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $350.5M | $130.3M |
| 总资产 | $451.9M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资NCMIPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | $29.9M | $94.4M | ||
| Q2 25 | $37.2M | $96.0M | ||
| Q1 25 | $59.8M | $93.2M | ||
| Q4 24 | $75.2M | $101.0M | ||
| Q3 24 | $49.5M | $96.7M | ||
| Q2 24 | $53.8M | $96.8M | ||
| Q1 24 | $57.1M | $107.2M |
总债务NCMIPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益NCMIPBYI
| Q4 25 | — | $130.3M | ||
| Q3 25 | $350.5M | $115.3M | ||
| Q2 25 | $350.0M | $104.7M | ||
| Q1 25 | $370.8M | $97.1M | ||
| Q4 24 | $411.2M | $92.1M | ||
| Q3 24 | $385.5M | $71.1M | ||
| Q2 24 | $387.9M | $48.5M | ||
| Q1 24 | $402.3M | $51.0M |
总资产NCMIPBYI
| Q4 25 | — | $216.3M | ||
| Q3 25 | $451.9M | $202.9M | ||
| Q2 25 | $462.0M | $194.9M | ||
| Q1 25 | $503.8M | $196.2M | ||
| Q4 24 | $568.6M | $213.3M | ||
| Q3 24 | $526.1M | $220.7M | ||
| Q2 24 | $527.2M | $205.0M | ||
| Q1 24 | $538.6M | $214.1M |
负债/权益比NCMIPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.0M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-2.0M | $14.4M |
| 自由现金流率自由现金流/营收 | -3.2% | 19.1% |
| 资本支出强度资本支出/营收 | 1.6% | 0.0% |
| 现金转化率经营现金流/净利润 | -0.63× | — |
| 过去12个月自由现金流最近4个季度 | $24.8M | $41.7M |
8季度趋势，按日历期对齐
经营现金流NCMIPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | $-1.0M | $9.7M | ||
| Q2 25 | $-4.9M | $14.1M | ||
| Q1 25 | $6.0M | $3.6M | ||
| Q4 24 | $30.5M | $15.6M | ||
| Q3 24 | $-2.0M | $11.0M | ||
| Q2 24 | $7.7M | $1.0M | ||
| Q1 24 | $24.1M | $11.2M |
自由现金流NCMIPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | $-2.0M | $9.7M | ||
| Q2 25 | $-6.6M | $14.1M | ||
| Q1 25 | $5.3M | $3.6M | ||
| Q4 24 | $28.1M | $15.6M | ||
| Q3 24 | $-2.6M | $11.0M | ||
| Q2 24 | $6.4M | $1.0M | ||
| Q1 24 | $22.6M | — |
自由现金流率NCMIPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | -3.2% | 17.7% | ||
| Q2 25 | -12.7% | 26.8% | ||
| Q1 25 | 15.2% | 7.7% | ||
| Q4 24 | 32.6% | 26.4% | ||
| Q3 24 | -4.2% | 13.7% | ||
| Q2 24 | 11.7% | 2.1% | ||
| Q1 24 | 60.4% | — |
资本支出强度NCMIPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | 1.6% | 0.0% | ||
| Q2 25 | 3.3% | 0.0% | ||
| Q1 25 | 2.0% | 0.1% | ||
| Q4 24 | 2.8% | 0.0% | ||
| Q3 24 | 1.0% | 0.0% | ||
| Q2 24 | 2.4% | 0.0% | ||
| Q1 24 | 4.0% | 0.0% |
现金转化率NCMIPBYI
| Q4 25 | — | — | ||
| Q3 25 | -0.63× | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | 1.23× | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NCMI
| National Advertising Revenue | $49.9M | 79% |
| Local Advertising Revenue | $9.6M | 15% |
| Founding Member Advertising Revenue From Beverage Concessionaire Agreements | $3.9M | 6% |
PBYI
暂无分部数据
